Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective immunity afforded by attenuated, PhoP‐deficient Mycobacterium tuberculosis is associated with sustained generation of CD4+ T‐cell memory
Jonathan K. Nambiar, Rachel Pinto, Nacho Aguiló, et al.
European Journal of Immunology (2011) Vol. 42, Iss. 2, pp. 385-392
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials
Ainhoa Arbués, Nacho Aguiló, Jesús Gonzalo‐Asensio, et al.
Vaccine (2013) Vol. 31, Iss. 42, pp. 4867-4873
Closed Access | Times Cited: 235
The Mycobacterial Cell Envelope--Lipids
Mary Jackson
Cold Spring Harbor Perspectives in Medicine (2014) Vol. 4, Iss. 10, pp. a021105-a021105
Open Access | Times Cited: 210
The cell envelope glycoconjugates ofMycobacterium tuberculosis
Shiva K. Angala, Juan M. Belardinelli, Emilie Huc‐Claustre, et al.
Critical Reviews in Biochemistry and Molecular Biology (2014) Vol. 49, Iss. 5, pp. 361-399
Open Access | Times Cited: 138
Bovine Tuberculosis in Cattle: Vaccines, DIVA Tests, and Host Biomarker Discovery
H. M. Vordermeier, Gareth J. Jones, Bryce M. Buddle, et al.
Annual Review of Animal Biosciences (2016) Vol. 4, Iss. 1, pp. 87-109
Open Access | Times Cited: 125
Evolutionary Landscape of the Mycobacterium tuberculosis Complex from the Viewpoint of PhoPR: Implications for Virulence Regulation and Application to Vaccine Development
Esther Broset, Carlos Martı́n, Jesús Gonzalo‐Asensio
mBio (2015) Vol. 6, Iss. 5
Open Access | Times Cited: 84
MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic
Jesús Gonzalo‐Asensio, Dessislava Marinova, Carlos Martı́n, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 83
Protective CD4 T Cells Targeting Cryptic Epitopes of Mycobacterium tuberculosis Resist Infection-Driven Terminal Differentiation
Joshua S. Woodworth, Claus Aagaard, Per Brinch Hansen, et al.
The Journal of Immunology (2014) Vol. 192, Iss. 7, pp. 3247-3258
Open Access | Times Cited: 69
Tuberculosis Vaccines – state of the art, and novel approaches to vaccine development
Christopher da Costa, Barry Walker, Aurelio Bonavia
International Journal of Infectious Diseases (2015) Vol. 32, pp. 5-12
Open Access | Times Cited: 62
Vaccine against tuberculosis: what’s new?
Carlotta Montagnani, Elena Chiappini, Luisa Galli, et al.
BMC Infectious Diseases (2014) Vol. 14, Iss. S1
Open Access | Times Cited: 59
Vaccine Development for Tuberculosis: Current Progress
Ian M. Orme
Drugs (2013) Vol. 73, Iss. 10, pp. 1015-1024
Open Access | Times Cited: 58
Identification of the Avian Pasteurella multocida phoP Gene and Evaluation of the Effects of phoP Deletion on Virulence and Immunogenicity
Kangpeng Xiao, Qing Liu, Xueyan Liu, et al.
International Journal of Molecular Sciences (2015) Vol. 17, Iss. 1, pp. 12-12
Open Access | Times Cited: 57
Prime–boost approaches to tuberculosis vaccine development
Neha Dalmia, Alistair J. Ramsay
Expert Review of Vaccines (2012) Vol. 11, Iss. 10, pp. 1221-1233
Open Access | Times Cited: 53
Vaccination with a BCG Strain Overexpressing Ag85B Protects Cattle against Mycobacterium bovis Challenge
Caroline Rizzi, María Verónica Bianco, Federico Carlos Blanco, et al.
PLoS ONE (2012) Vol. 7, Iss. 12, pp. e51396-e51396
Open Access | Times Cited: 52
Novel vaccine approaches for protection against intracellular pathogens
Kristin Griffiths, Shabaana A. Khader
Current Opinion in Immunology (2014) Vol. 28, pp. 58-63
Open Access | Times Cited: 51
MTBVAC from discovery to clinical trials in tuberculosis-endemic countries
Dessislava Marinova, Jesús Gonzalo‐Asensio, Nacho Aguiló, et al.
Expert Review of Vaccines (2017) Vol. 16, Iss. 6, pp. 565-576
Open Access | Times Cited: 47
DNA Consensus Sequence Motif for Binding Response Regulator PhoP, a Virulence Regulator of Mycobacterium tuberculosis
Xiaoyuan He, Shuishu Wang
Biochemistry (2014) Vol. 53, Iss. 51, pp. 8008-8020
Open Access | Times Cited: 45
Tuberculosis Vaccine Types and Timings
Ian M. Orme
Clinical and Vaccine Immunology (2014) Vol. 22, Iss. 3, pp. 249-257
Open Access | Times Cited: 40
The present and future of tuberculosis vaccinations
Nicola Principi, Susanna Esposito
Tuberculosis (2014) Vol. 95, Iss. 1, pp. 6-13
Closed Access | Times Cited: 38
Increased TNF-α/IFN-γ/IL-2 and Decreased TNF-α/IFN-γ Production by Central Memory T Cells Are Associated with Protective Responses against Bovine Tuberculosis Following BCG Vaccination
Mayara F. Maggioli, Mitchell V. Palmer, Tyler C. Thacker, et al.
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 37
Current status of new tuberculosis vaccine in children
Yu Pang, Aihua Zhao, Chad Cohen, et al.
Human Vaccines & Immunotherapeutics (2016) Vol. 12, Iss. 4, pp. 960-970
Open Access | Times Cited: 36
Protection versus pathology in tuberculosis: recent insights
Andrea M. Cooper, Egídio Torrado
Current Opinion in Immunology (2012) Vol. 24, Iss. 4, pp. 431-437
Open Access | Times Cited: 36
Attenuated Mycobacterium tuberculosis SO2 Vaccine Candidate Is Unable to Induce Cell Death
Adriana Aporta, Ainhoa Arbués, Nacho Aguiló, et al.
PLoS ONE (2012) Vol. 7, Iss. 9, pp. e45213-e45213
Open Access | Times Cited: 33
Current and novel approaches to vaccine development against tuberculosis
Mark J. Cayabyab, Lilia Macovei, Antonio Campos‐Neto
Frontiers in Cellular and Infection Microbiology (2012) Vol. 2
Open Access | Times Cited: 31
A century of attempts to develop an effective tuberculosis vaccine: Why they failed?
Saman Soleimanpour, Atieh Yaghoubi, Fereshteh Sadat Seddighinia, et al.
International Immunopharmacology (2022) Vol. 109, pp. 108791-108791
Closed Access | Times Cited: 13
MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice
Esther Broset, Narcı́s Saubi, Núria Guitart, et al.
Molecular Therapy — Methods & Clinical Development (2019) Vol. 13, pp. 253-264
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top